TAP Pharmaceutical Products Inc.
675 North Field Drive
Lake Forest
Illinois
60015
United States
Tel: 800-621-1020
22 articles about TAP Pharmaceutical Products Inc.
-
A consumer advocacy group, Public Citizen, has petitioned the FDA to pull the drug, Uloric, off the market.
-
TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
5/19/2008
-
Shire Pharmaceuticals Group plc and TAP Pharmaceutical Products Inc. Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative Colitis
3/26/2008
-
Takeda Pharmaceutical Co. Ltd. to Pay Abbott Laboratories up to $1.5B in Venture Split
3/20/2008
-
TAP Pharmaceutical Products Inc. Files New Drug Application for TAK-390MR in Patients with Acid-Related Disorders
1/4/2008
-
Out at Work: Diversity in the Pharmaceutical and Biotechnology Industries
6/29/2007
-
Takeda Pharmaceuticals North America, Inc. and TAP Pharmaceutical Products Inc. to Promote Sucampo Pharmaceuticals, Inc.'s AMITIZA(R) in the United States
2/26/2007
-
First French Pharma To Fully Automate Cell Culture Chooses CompacT SelecT™ From The Automation Partnership
11/29/2006
-
Novartis Corporation And TAP Pharmaceutical Products Inc. To Co-Promote Genital Herpes Drug
9/29/2006
-
FDA Refuses Again To Approve TAP Pharmaceutical Products Inc.'s Gout Drug
8/14/2006
-
TAP Pharmaceutical Products Inc. Release: Second Annual Kids Create. Parents Relate. National Drawing And Coloring Contest Kicks-Off To Help Raise Awareness Of Pediatric GERD
6/14/2006
-
TAP Pharmaceutical Products Inc. Foundation Establishes TAP Research Endowment Fund
5/22/2006
-
TAP Pharmaceutical Products Inc. Release: Children With Pediatric Gastroesophageal Reflux Disease (GERD) Can Go Undiagnosed For Months According To New Survey Of Moms
3/22/2006
-
Legal Action Instituted By Abbott Laboratories Against Takeda Pharmaceutical Co. Ltd. Dismissed
3/2/2006
-
Santarus Inc. Receives Notice From TAP Pharmaceutical Products Inc. Of Intent To Terminate Sublicense Agreement
1/9/2006
-
TAP Rushes To Develop Antidote For Prevacid Sales Pain
1/20/2005
-
Drug Companies Launch New Discount Card
1/12/2005
-
The United States District Court For The District Of Massachusetts Release: Court To Notify Those Who Paid For Prescription Drug Lupron(R), As A Result Of A Nationwide Class Action Lawsuit Settlement
1/7/2005
-
TAP Jury: "Not Enough Proof"
7/28/2004
-
Australia-Based Norwood Seeks IPO On London's AIM Exchange
4/7/2004